| Literature DB >> 25699137 |
Brandon J Peel1, Gordon Hagen1, Kalaivani Krishnamurthy1, Jean-Paul Desaulniers1.
Abstract
Short interfering RNAs (siRNAs) have tremendous potential as a new class of next-generation therapeutics; however, their progress is lagging due to issues related to stability, biodistribution, and cell-membrane permeability. To overcome these issues, there is widespread interest in chemically modifying siRNAs. In this study, siRNAs that contain a triazole-backbone unit with pyrimidine-modified hydrophobic substituents were synthesized and examined for their gene-silencing activity. In our study, we generated a library of siRNAs that target both a plasmid reporter system and an endogenous gene target, bcl-2. Our results indicate that these unique modifications are well tolerated within the RNA interference pathway. In addition, a cholesterol-modified triazole-linked siRNA targeting the exogenous target firefly luciferase was capable of gene-silencing at levels greater than 80% in the absence of a carrier complex.Entities:
Keywords: Short interfering RNAs; down regulation; gene expression; nucleic acid chemistry; oligonucleotides
Year: 2014 PMID: 25699137 PMCID: PMC4329592 DOI: 10.1021/ml500260j
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345